 | articles |
Browse Journal of Immune Based Therapies and Vaccines by date
| | [1] | | [3] | | [1] | | [1] | | [1] | | [1] | | [1] | | [1] | | [2] | | [1] | | [1] | | [1] | | [1] | | [1] | | [3] | | [1] | | [1] | | [2] | | [1] | | [1] | | [1] | | [1] | | [2] | | [1] | | [1] | | [1] | | [2] | | [1] | | [1] | | [1] | | [2] | | [2] | | [2] | | [3] | | [1] | | [1] |
| | Latest articles [more info]
| Original research
  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella Jerome S Harms, Marina A Durward, Diogo M Magnani, Gary A Splitter Journal of Immune Based Therapies and Vaccines 2009, 7:1 (6 January 2009) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  Vaccine based on a ubiquitous cysteinyl protease and streptococcal pyrogenic exotoxin A protects against Streptococcus pyogenes sepsis and toxic shock Robert G Ulrich Journal of Immune Based Therapies and Vaccines 2008, 6:8 (31 October 2008) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up Anna A Herasimtschuk, Samantha J Westrop, Graeme J Moyle, Jocelyn S Downey, Nesrina Imami Journal of Immune Based Therapies and Vaccines 2008, 6:7 (31 October 2008) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  CXCL10 blockade protects mice from cyclophosphamide-induced cystitis Senthilkumar K Sakthivel, Udai P Singh, Shailesh Singh, Dennis D Taub, Kristian R Novakovic, James W Lillard Jr Journal of Immune Based Therapies and Vaccines 2008, 6:6 (28 October 2008) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock Garry L Morefield, Ralph F Tammariello, Bret K Purcell, Patricia L Worsham, Jennifer Chapman, Leonard A Smith, Jason B Alarcon, John A Mikszta, Robert G Ulrich Journal of Immune Based Therapies and Vaccines 2008, 6:5 (3 September 2008) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection Jonathan B Angel, Curtis L Cooper, Jennifer Clinch, Charlene D Young, Andreane Chenier, Karl G Parato, Michael Lautru, Heather Davis, Donald W Cameron Journal of Immune Based Therapies and Vaccines 2008, 6:4 (12 August 2008) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers Curtis L Cooper, Navneet K Ahluwalia, Susan M Efler, Jörg Vollmer, Arthur M Krieg, Heather L Davis Journal of Immune Based Therapies and Vaccines 2008, 6:3 (9 June 2008) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  Use of ultraviolet-light irradiated multiple myeloma cells as immunogens to generate tumor-specific cytolytic T lymphocytes Charles A Gullo, William YK Hwang, Chye K Poh, Melvin Au, Geraline Cow, Gerrard Teoh Journal of Immune Based Therapies and Vaccines 2008, 6:2 (28 April 2008) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  A new approach for the large-scale generation of mature dendritic cells from adherent PBMC using roller bottle technology Ryan E Campbell-Anson, Diane Kentor, Yi J Wang, Kathryn M Bushnell, Yufeng Li, Luis M Vence, Laszlo G Radvanyi Journal of Immune Based Therapies and Vaccines 2008, 6:1 (6 March 2008) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Review
  An HIV/AIDS Prophylactic vaccine is possible Qiu Zhong, Ronald B Luftig Journal of Immune Based Therapies and Vaccines 2007, 5:12 (19 December 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant Cassandra D Kelly, Chris O'Loughlin, Frank B Gelder, Johnny W Peterson, Laurie E Sower, Nick M Cirino Journal of Immune Based Therapies and Vaccines 2007, 5:11 (22 October 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  Specific antibody response of mice after immunization with COS-7 cell derived avian influenza virus (H5N1) recombinant proteins Navin Horthongkham, Tananun Srihtrakul, Niracha Athipanyasilp, Sontana Siritantikorn, Wannee Kantakamalakul, Yong Poovorawan, Ruengpung Sutthent Journal of Immune Based Therapies and Vaccines 2007, 5:10 (3 October 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  CTLA-4 blockade during dendritic cell based booster vaccination influences dendritic cell survival and CTL expansion Anders E Pedersen, Franca Ronchese Journal of Immune Based Therapies and Vaccines 2007, 5:9 (29 July 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
  Age-related waning of in vitro Interferon- levels against r32kDaBCG in BCG vaccinated children B Anuradha, CM Santosh, V Hari Sai Priya, G Suman Latha, KJR Murthy, Valluri Vijaya Lakshmi Journal of Immune Based Therapies and Vaccines 2007, 5:8 (7 June 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
 Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors Smita A Ghanekar, Sonny Bhatia, Joyce J Ruitenberg, Corazon DeLa Rosa, Mary L Disis, Vernon C Maino, Holden T Maecker, Cory A Waters Journal of Immune Based Therapies and Vaccines 2007, 5:7 (3 May 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central] Original research
 A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy Gareth AD Hardy, Nesrina Imami, Mark R Nelson, Ann K Sullivan, Ron Moss, Marlén MI Aasa-Chapman, Brian Gazzard, Frances M Gotch Journal of Immune Based Therapies and Vaccines 2007, 5:6 (11 April 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
 IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study Chrystelle Brignone, Caroline Grygar, Manon Marcu, Gaëlle Perrin, Frédéric Triebel Journal of Immune Based Therapies and Vaccines 2007, 5:5 (29 March 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Original research
 Evaluation of a recombinant human gelatin as a substitute for a hydrolyzed porcine gelatin in a refrigerator-stable Oka/Merck live varicella vaccine Vladimir Liska, Stacey A Bigert, Philip S Bennett, David Olsen, Robert Chang, Carl J Burke Journal of Immune Based Therapies and Vaccines 2007, 5:4 (23 February 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles] Correction
 Correction: Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses So-Yon Lim, Matt Meyer, Richard A Kjonaas, Swapan K Ghosh Journal of Immune Based Therapies and Vaccines 2007, 5:3 (22 February 2007) [Abstract] [Full Text] [PDF] Original research
 Improved generation of anti-tumor immunity by antigen dose limitation Joshua D Shofner, Juan G Vasquez, Carole L Berger, Richard L Edelson Journal of Immune Based Therapies and Vaccines 2007, 5:2 (9 February 2007) [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
|
|  
|